121 related articles for article (PubMed ID: 9270371)
1. Piperbetol, methylpiperbetol, piperol A and piperol B: a new series of highly specific PAF receptor antagonists from Piper betle.
Zeng HW; Jiang YY; Cai DG; Bian J; Long K; Chen ZL
Planta Med; 1997 Aug; 63(4):296-8. PubMed ID: 9270371
[TBL] [Abstract][Full Text] [Related]
2. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
Bin Z; Kun L
Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
[TBL] [Abstract][Full Text] [Related]
4. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
5. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
8. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
9. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
12. [Antagonistic effect of myricetin on platelet activing factor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Yao Xue Xue Bao; 2003 Nov; 38(11):831-3. PubMed ID: 14991995
[TBL] [Abstract][Full Text] [Related]
13. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
15. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
Wang XD; Bian RL
Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):524-7. PubMed ID: 2130617
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
17. Frangulin B, an antagonist of collagen-induced platelet aggregation and adhesion, isolated from Rhamnus formosana.
Teng CM; Lin CH; Lin CN; Chung MI; Huang TF
Thromb Haemost; 1993 Dec; 70(6):1014-8. PubMed ID: 8165593
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor.
Kassuya CA; Silvestre A; Menezes-de-Lima O; Marotta DM; Rehder VL; Calixto JB
Eur J Pharmacol; 2006 Sep; 546(1-3):182-8. PubMed ID: 16925995
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
